natgillin/translations-raw huggingface dataset:
As for all insulins, injection sites and infusion sites within an-injection area (abdomen, thigh or upper arm) must be rotated from one injection to the next. 
Tako kot pri vseh insulinih je treba mesta injiciranja in infundiranja na posameznem predelu (trebuh, stegno ali nadlaket) od injekcije do injekcije krožno menjavati.
If your SoloStar is in cool storage, take it out 1 to 2 hours before you inject to allow it to warm up to room temperature. 
Če imate SoloStar shranjen na hladnem, ga vzemite iz hladilnika 1 do 2 uri pred injiciranjem, da se ogreje na sobno temperaturo.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (PRE-FILLED PEN for SoloStar) 
PODATKI NA ZUNANJI OVOJNINI ZUNANJA OVOJNINA (Napolnjen injekcijski peresnik za SoloStar)
MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ALUMINIUM FOIL USED FOR SEALING TRANSPARENT PLASTIC TRAY CONTAINING THE CARTRIDGE 
BESEDILO, NATISNJENO NA ALUMINIJSKI FOLIJI, UPORABLJENI ZA ZAPRTJE PROSOJNEGA PLASTIČNEGA LEŽIŠČA, V KATEREM JE VLOŽEK
Apidra can be injected in the abdominal wall, the thigh or upper arm or by continuous infusion in the abdominal wall. 
Zdravilo Apidra lahko injicirate v trebušno steno, stegno ali nadlaket ali ga dajete s stalno infuzijo v trebušno steno.
It may also be given intravenously by healthcare professionals under close supervision by a doctor. 
Zdravilo Apidra je mogoče dati tudi intravensko, vendar ga sme tako uporabiti samo zdravstveno osebje pod strogim nadzorom zdravnika.
Apidra can be administered intravenously. 
Zdravilo Apidra je mogoče dati tudi intravensko.
In a study in patients with type 2 diabetes mellitus after subcutaneous administration of 0.2 Units/kg insulin glulisine, the Cmax was 91 µUnits/ml with the interquartile range from 78 to 104 µUnits/ml. 
V študiji pri bolnikih z diabetesom mellitusom tipa 2 je bil Cmax po subkutani aplikaciji 0,2 enot/kg insulina glulisin 91 µenot/ml; interkvartilni razpon je bil od 78 do 104 µenot/ml.
QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains 100 Units insulin glulisine (equivalent to 3.49 mg). 
KAKOVOSTNA IN KOLIČINSKA SESTAVA En mililiter vsebuje 100 enot insulina glulisin (kar ustreza 3,49 mg).
CLINICAL PARTICULARS 
Klinične študije
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (10 ml vial) 
PODATKI NA ZUNANJI OVOJNINI ZUNANJA OVOJNINA (10 ml viala)
After subcutaneous administration, insulin glulisine is eliminated more rapidly than regular human insulin with an apparent half-life of 42 minutes compared to 86 minutes. 
Po subkutani uporabi se insulin glulisin izloča hitreje (navidezni razpolovni čas: 42 minut) kot navadni humani insulin (navidezni razpolovni čas: 86 minut).
Refer to the manufacturer's instructions for using the pen. 
Glejte izdelovalčeva navodila za uporabo injekcijskega peresnika.
This medicine contains less than 1 mmol (23 mg) sodium per dose, i.e. it is essentially ‘sodium-free'. 
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar pomeni, da je praktično »brez natrija«.
Also contains: metacresol, sodium chloride, trometamol, polysorbate 20, concentrated hydrochloric acid, sodium hydroxide, water for injections (see leaflet for further information). 
Vsebuje tudi: metakrezol, natrijev klorid, trometamol, polisorbat 20, koncentrirano klorovodikovo kislino, natrijev hidroksid, vodo za injekcije (za dodatne informacije glejte priloženo navodilo).
Do not use this medicine if it does not appear clear and colourless. 
Zdravila Apidra ne uporabljajte, če ni bistro in brezbarvno.
SoloStar is a pre-filled disposable pen containing insulin glulisine. 
SoloStar je napolnjen injekcijski peresnik, ki vsebuje insulin glulisin.
In a study in patients with type 1 diabetes mellitus after subcutaneous administration of 0.15 Units/kg, for insulin glulisine the Tmax was 55 minutes and Cmax was 82 ± 1.3 µUnits/ml compared to a Tmax of 82 minutes and a Cmax of 46 ± 1.3 µUnits/ml for regular human insulin. 
V študiji pri bolnikih z diabetesom mellitusom tipa 1 sta bila po subkutani uporabi insulina glulisin v odmerku 0,15 enot/kg, tmax 55 minut in Cmax 82 ± 1,3 µenot/ml, po subkutani uporabi navadnega humanega insulina v enakem odmerku pa tmax 82 minut in Cmax 46 ± 1,3 µenot/ml.
A 12-week phase III clinical study performed in patients with type 1 diabetes mellitus receiving insulin glargine as basal therapy indicate that the immediate post-meal administration of insulin glulisine provides efficacy that was comparable to immediate pre-meal insulin glulisine (0-15 minutes) or regular insulin (30-45 minutes). 
12-tedenska klinična študija faze III pri bolnikih z diabetesom mellitusom tipa 1, ki so kot bazalno terapijo dobivali insulin glargin, kaže, da apliciranje insulina glulisin takoj po obroku zagotavlja primerljivo učinkovitost kot uporaba insulina glulisin tik (0-15 minut) pred obrokom ali navadnega humanega insulina 30-45 minut pred obrokom.
Apidra should be administered subcutaneously in the abdominal wall, thigh or deltoid or by continuous infusion in the abdominal wall. 
Zdravilo Apidra je treba aplicirati subkutano v trebušno steno, stegno ali deltoidni predel ali s stalno infuzijo v trebušno steno.
Your insulin dose may need to be changed during pregnancy and after giving birth. 
Med nosečnostjo in po porodu bo morda treba spremeniti odmerek insulina.
Each vial contains 10 ml solution (1000 Units). 
Ena viala vsebuje 10 ml raztopine (1000 enot).
Hyperglycaemia can cause diabetic ketoacidosis (build-up of acid in the blood because the body is breaking down fat instead of sugar). 
Hiperglikemija lahko povzroči diabetično ketoacidozo (kopičenje kisline v krvi, ker telo za pridobivanje energije razgrajuje maščobe namesto sladkorja).
Subcutaneous or intravenous use 
Subkutana ali intravenska uporaba
Insulin glulisine has a more rapid onset of action and a shorter duration of action than regular human insulin. 
Insulin glulisin začne delovati hitreje in deluje krajši čas kot navadni humani insulin.
The dose can then be selected. 
Potem lahko nastavite odmerek.
If Apidra is mixed with NPH human insulin, Apidra should be drawn into the syringe first. 
Če insulin Apidra mešate s humanim insulinom NPH, ga morate v brizgo potegniti prvega.
Instructions for proper use 
Navodila za ustrezno ravnanje
Apidra should be used in regimens that include an intermediate or long acting insulin or basal insulin analogue and can be used with oral hypoglycaemic agents. 
Zdravilo Apidra je treba uporabljati v shemah, ki vključujejo srednjedolgo- ali dolgodelujoč insulin ali bazalni insulinski analog; zdravilo je mogoče uporabljati tudi s peroralnimi antidiabetiki.
METHOD OF ADMINISTRATION Use specific pens: see leaflet. 
POSTOPEK UPORABE Uporabljajte specifične injekcijske peresnike: glejte navodilo za uporabo.
Insulin glulisine shows low plasma protein binding, similar to human insulin. 
Vezava insulina glulisin na plazemske proteine je majhna, podobno kot pri humanem insulinu.
Limited pharmacokinetic data are available in elderly patients with diabetes mellitus. 
Na voljo so le skopi podatki o farmakokinetiki pri starejših bolnikih z diabetesom mellitusom.
A phase I study in patients with type 1 diabetes mellitus assessed the glucose lowering profiles of insulin glulisine and regular human insulin administered subcutaneously at a dose of 0.15 Units/kg, at different times in relation to a 15-minute standard meal. 
Študija faze I pri bolnikih z diabetesom mellitusom tipa 1 je ocenjevala znižanje glukoze z insulinom glulisin in navadnim humanim insulinom, apliciranima subkutano v odmerku 0,15 e./kg ob različnih časih glede na 15-minutni standardni obrok.
The first symptoms which alert you to hypoglycaemia ("warning symptoms") may change, be weaker or may be missing altogether if: - you are elderly, - you have had diabetes for a long time, - you suffer from a certain type of nervous disease (diabetic autonomic neuropathy), - you have recently suffered hypoglycaemia (for example the day before) or if it develops slowly, - you have almost normal or, at least, greatly improved blood sugar levels, - you are taking or have taken certain other medicines (see section 2, "Other medicines and 
Prvi simptomi, ki opozarjajo na hipoglikemijo ("opozorilni simptomi"), se lahko spremenijo, oslabijo ali jih celo sploh ni več, če - ste starejši, - imate sladkorno bolezen že dolgo, - imate določeno vrsto okvare živčevja (diabetična avtonomna nevropatija), - ste nedavno (na primer prejšnji dan) doživeli hipoglikemijo ali če se hipoglikemija pojavi počasi, - imate skoraj normalno ali vsaj močno izboljšano koncentracijo krvnega sladkorja, - uporabljate ali ste uporabljali določena druga zdravila (glejte poglavje 2, "Uporaba drugih zdravil").
To prevent any kind of contamination, the reusable pen should be used only by you. 
Da preprečite kakršnokoli onesnaženje, smete injekcijski peresnik za večkratno uporabo uporabljati samo vi.
The pharmacokinetic properties of insulin glulisine have not been investigated in patients with decreased liver function. 
Farmakokinetične lastnosti insulina glulisin pri bolnikih z zmanjšanim delovanjem jeter niso raziskane.
A 26-week phase III clinical study followed by a 26-week extension safety study was conducted to compare insulin glulisine (0-15 minutes before a meal) with regular human insulin (30-45 minutes before a meal) injected subcutaneously in patients with type 2 diabetes mellitus also using NPH insulin as basal insulin. 
26-tedenska klinična študija faze III, kateri je sledila 26-tedenska nadaljevalna študija varnosti, je primerjala insulin glulisin (0-15 minut pred obrokom) z navadnim humanim insulinom (30-45 minut pred obrokom), injiciranima subkutano, in sicer pri bolnikih z diabetesom mellitusom tipa 2, ki so uporabljali tudi insulin NPH kot bazalni insulin.
• Skin and allergic reactions at the injection site Reactions at the injection site may occur (such as reddening, unusually intense pain on injection, itching, hives, swelling or inflammation). 
Pojavijo se lahko reakcije na mestu injiciranja (kot so rdečina, neobičajno močna bolečina pri injiciranju, srbenje, koprivnica, oteklina ali vnetje).
Do not put Apidra next to the freezer compartment or a freezer pack. 
Zdravila Apidra ne shranjujte v bližini zamrzovalnega razdelka ali zamrzovalnega vložka.
Sanofi-Aventis Deutschland GmbH Industriepark Höchst, D-65926 Frankfurt Germany 
Sanofi-Aventis Deutschland GmbH Industriepark Höchst, D-65926 Frankfurt Nemčija
Type 1 diabetes mellitus-Paediatric 
Diabetes mellitus tipa 1 - otroci
- If you have missed a dose of Apidra or if you have not injected enough insulin, your blood sugar level may become too high (hyperglycaemia). 
- Če ste izpustili odmerek insulina Apidra ali če si niste injicirali dovolj insulina, se lahko koncentracija krvnega sladkorja preveč zviša (hiperglikemija).
Care should be taken to ensure that a blood vessel has not been entered. 
Paziti je treba, da zdravilo ne pride v žilo.
Each vial contains 10 ml of solution for injection, equivalent to 1000 Units. 
Vsaka viala vsebuje 10 ml raztopine za injiciranje, kar ustreza 1000 enotam.
Apidra 100 Units/ml solution for injection in a vial EU/1/04/285/001-004 
Apidra 100 enot/ml raztopina za injiciranje v viali EU/1/04/285/001-004
Apidra in a pre-filled pen is only suitable for injecting just under the skin (see also section 3). 
Zdravilo Apidra v napolnjenem injekcijskem peresniku je primerno samo za injiciranje tik pod kožo(glejte tudi poglavje 3).
You may need to talk about - the availability of your insulin in the country you are visiting, - supplies of insulin, injection syringes etc, - correct storage of your insulin while travelling, - timing of meals and insulin administration while travelling, - the possible effects of changing to different time zones, - possible new health risks in the countries to be visited, - what you should do in emergency situations when you feel unwell or become ill. 
Med vprašanji, o katerih se boste morali pogovoriti, so - dosegljivost vašega insulina v državi, v katero se odpravljate, - zaloge insulina, injekcijskih brizg itd., - pravilno shranjevanje insulina med potovanjem, - časovni razpored obrokov in dajanje insulina med potovanjem, - možni vplivi spremembe časovnih pasov, - možna nova zdravstvena tveganja v državah, ki jih boste obiskali, - kaj storiti v nujnih primerih, ko se ne počutite dobro ali zbolite.
Apidra SoloStar 100 Units/ml solution for injection in a pre-filled pen EU/1/04/285/029-036 
Apidra SoloStar 100 enot/ml raztopina za injiciranje v napolnjenem injekcijskem peresniku EU/1/04/285/029-036
You may need to talk about - the availability of your insulin in the country you are visiting, - supplies of insulin, needles, etc, - correct storage of your insulin while travelling, - timing of meals and insulin administration while travelling, - the possible effects of changing to different time zones, - possible new health risks in the countries to be visited, - what you should do in emergency situations when you feel unwell or become ill. 
Med vprašanji, o katerih se boste morali pogovoriti, so - dosegljivost vašega insulina v državi, v katero se odpravljate, - zaloge insulina, igel itd., - pravilno shranjevanje insulina med potovanjem, - časovni razpored obrokov in dajanje insulina med potovanjem, - možni vplivi spremembe časovnih con, - možna nova zdravstvena tveganja v državah, ki jih boste obiskali, - kaj storiti v nujnih primerih, ko se ne počutite dobro ali zbolite.
Injection sites and infusion sites within an injection area (abdomen, thigh or deltoid) should be rotated from one injection to the next. 
Mesto injiciranja oz. infundiranja na posameznem predelu (trebuh, stegno, deltoidni predel) je treba od injekcije do injekcije krožno menjati.
Substances that may enhance the blood-glucose-lowering activity and increase susceptibility to hypoglycaemia include oral antidiabetic medicinal products, angiotensin converting enzyme (ACE) inhibitors, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors (MAOIs), pentoxifylline, propoxyphene, salicylates and sulphonamide antibiotics. 
Med zdravili, ki lahko stopnjujejo učinek znižanja glukoze v krvi in zvečajo nagnjenost k hipoglikemiji, so peroralni antidiabetiki, zaviralci angiotenzinske konvertaze (ACE), dizopiramid, fibrati, fluoksetin, zaviralci monoaminooksidaze (MAO), pentoksifilin, propoksifen, salicilati in sulfonamidni antibiotiki.
Fertility Animal reproduction studies with insulin glulisine have not revealed any adverse effects on fertility. 
Študije na živalih ne kažejo neposrednih škodljivih učinkov na plodnost.
When used with an insulin infusion pump, Apidra must not be mixed with other medicinal products. 
Kadar se insulin Apidra uporablja v črpalki za infundiranje insulina, se ga ne sme mešati z nobenim drugim zdravilom.
Data indicated that insulin glulisine administered 2 minutes before the meal gives similar postprandial glycaemic control compared to regular human insulin given 30 minutes before the meal. 
Podatki kažejo, da insulin glulisin, apliciran 2 minuti pred obrokom, povzroči podobno postprandialno urejenost glikemije kot navadni humani insulin, uporabljen 30 minut pred obrokom.
Patients administering Apidra by CSII must have an alternative insulin delivery system available in case of pump system failure (see section 4.4 and 4.8). 
Bolniki, ki zdravilo Apidra uporabljajo v CSII, morajo vedno imeti na voljo še drug sistem za dajanje insulina za primer, da sistem s črpalko odpove (glejte poglavji 4.4 in 4.8).
Systemic allergic reactions are side effects reported uncommonly (may affect up to 1 in 100 people). 
Občasno se lahko pojavijo sistemske alergijske reakcije (prizadanejo lahko največ 1 od 100 bolnikov).
When given 2 minutes prior to meal, insulin glulisine provided better postprandial control than regular human insulin given 2 minutes before the meal. 
Insulin glulisin, uporabljen 2 minuti pred obrokom, je zagotovil boljšo postprandialno urejenost kot navadni humani insulin, uporabljen 2 minuti pred obrokom.
MedDRA 
Odmerek
Each cartridge contains 3 ml solution (300 Units). 
Vsak vložek vsebuje 3 ml raztopine (300 enot).
Before use always attach a new needle, and perform a safety test. Only use needles that are compatible for use with SoloStar (see “SoloStar Instructions for use”). 
Uporabljajte le igle, primerne za uporabo s SoloStarjem (glejte "Navodila za ravnanje s SoloStarjem").
After removing the cap, the needle should be carefully attached straight onto the pen. 
Po odstranitvi pokrovčka injekcijskega peresnika morate iglo natančno namestiti naravnost na injekcijski peresnik.
Insulin glulisine given 15 minutes (GLULISINE post) after start of a meal compared to regular human insulin given 2 minutes (REGULAR pre) before start of the meal (figure 1C). 
Insulin glulisin, uporabljen 15 minut (GLULISIN - po) po začetku obroka, v primerjavi z navadnim humanim insulinom, uporabljenim 2 minuti (NAVADNI- pred) pred začetkom obroka (slika 1C).
Apidra in a pre-filled pen is only suitable for injecting just under the skin. 
Zdravilo Apidra v napolnjenem injekcijskem peresniku je primerno samo za injiciranje tik pod kožo.
Apidra with alcohol 
Zdravilo Apidra skupaj s hrano, pijačo in alkoholom
The pen in use must not be stored in a refrigerator. 
Vložka, ki ga uporabljate, ne smete shranjevati v hladilniku.
Each ml of the solution contains 100 Units of insulin glulisine (equivalent to 3.49 mg). 
Vsak mililiter raztopine vsebuje 100 enot insulina glulisin (kar ustreza 3,49 mg).
Then the injection button should be held down 10 seconds before withdrawing the needle. 
Preden se igla potegne iz kože, je treba gumb za injiciranje držati pritisnjen 10 sekund.
• General disorders and administration site conditions Systemic hypersensitivity reactions may include urticaria, chest tightness, dyspnoea, allergic dermatitis and pruritus. 
Sistemske preobčutljivostne reakcije lahko vključujejo urtikarijo, tiščanje v prsih, dispnejo, alergijski dermatitis in srbenje.
In a study with 18 male subjects with diabetes mellitus type 1, aged 21 to 50 years, insulin glulisine displays dose-proportionality for early, maximum and total exposure in the dose range 0.075 to 0.4 Units/kg. 
V študiji z 18 osebami moškega spola z diabetesom mellitusom tipa 1, starimi od 21 do 50 let, je bila zgodnja, največja in skupna izpostavljenost insulinu glulisin v razponu odmerkov od 0,075 do 0,4 enot/kg sorazmerna z odmerkom.
Upon regaining consciousness, administration of oral carbohydrate is recommended for the patient in order to prevent relapse. 
Ko se bolnik spet zave, je priporočljivo, da za preprečitev ponovitve peroralno dobi ogljikove hidrate.
Description of selected adverse reactions 
Opis izbranih neželenih učinkov Presnovne in prehranske motnje
Apidra in cartridges is only suitable for injecting just under the skin using a reusable pen (see also section 3). 
Zdravilo Apidra v vložku je primerno samo za injiciranje tik pod kožo z injekcijskim peresnikom za večkratno uporabo (glejte tudi poglavje 3).
Hepatic impairment The pharmacokinetic properties have not been investigated in patients with impaired liver function. 
Okvara jeter Farmakokinetične lastnosti pri bolnikih z okvarjenim delovanjem jeter niso raziskane.
Before using SoloStar, the Instructions for use included in the Package leaflet must be read carefully. 
Pred uporabo SoloStarja natančno preberite navodila za ravnanje z injekcijskim peresnikom v navodilu za uporabo.
Insulin glulisine administered 15 minutes after starting the meal gives similar glycaemic control as regular human insulin given 2 minutes before the meal (see figure 1). 
Insulin glulisin, uporabljen 15 minut po začetku obroka, doseže podobno urejenost glikemije kot navadni humani insulin, uporabljen 2 minuti pred obrokom (slika 1).
Step 2 Attach the needle 
Korak 2 Namestitev igle
Substances that may reduce the blood-glucose-lowering activity include corticosteroids, danazol, diazoxide, diuretics, glucagon, isoniazid, phenothiazine derivatives, somatropin, sympathomimetic medicinal products (e.g. epinephrine [adrenaline], salbutamol, terbutaline), thyroid hormones, oestrogens, progestins (e.g. in oral contraceptives), protease inhibitors and atypical antipsychotic medicinal products (e.g. olanzapine and clozapine). 
Med zdravili, ki lahko zmanjšajo učinek znižanja glukoze v krvi, so kortikosteroidi, danazol, diazoksid, diuretiki, glukagon, izoniazid, derivati fenotiazina, somatropin, simpatikomimetiki (npr. adrenalin, salbutamol, terbutalin), ščitnični hormoni, estrogeni, progestini (npr. v peroralnih kontraceptivih), zaviralci proteaz in atipični antipsihotiki (npr. olanzapin in klozapin).
- If you have injected too much Apidra, your blood sugar level may become too low (hypoglycaemia). 
Če ste injicirali preveč zdravila Apidra, se vam lahko koncentracija krvnega sladkorja preveč zniža (hipoglikemija).
Before first use, the pen must be stored at room temperature for 1 to 2 hours. 
Pred prvo uporabo mora biti injekcijski peresnik 1 do 2 uri na sobni temperaturi.
Insulin label must always be checked before each injection to avoid medication errors between insulin glulisine and other insulins (see section 4.4). 
Da bi se izognili napakam zdravljenja zaradi zamenjave med insulinom glulisin in drugimi insulini, je potrebno nalepko insulina vedno preveriti pred vsakim injiciranjem (glejte poglavje 4.4).
After first use: The product may be stored for a maximum of 4 weeks below 25°C. 
Po prvi uporabi: zdravilo lahko shranjujete največ 4 tedne pri temperaturi do 25°C.
No increase in the basal insulin dose was needed with insulin glulisine, in contrast to insulin lispro. 
V nasprotju z insulinom lispro ob insulinu glulisin ni bilo treba zvečati odmerka bazalnega insulina.
Local hypersensitivity reactions (redness, swelling and itching at the injection site) may occur during treatment with insulin. 
Med zdravljenjem z insulinom se lahko pojavijo lokalne preobčutljivostne reakcije (pordelost, oteklost in srbenje na mestu injiciranja).
In-use pens For storage conditions after first opening of the medicinal product, see section 6.3. 
Uporabljeni injekcijski peresniki Za pogoje shranjevanja po prvem odprtju zdravila glejte poglavje 6.3.
Change the infusion set and reservoir at least every 48 hours using aseptic technique. 
Infuzijski komplet in rezervoar morate zamenjati na 48 ur; menjavo morate opraviti aseptično.
Talk with your doctor, pharmacist or nurse about proper injection technique before using SoloStar. 
Preden začnete uporabljati SoloStar, se pogovorite s svojim zdravnikom, s farmacevtom ali z medicinsko sestro o pravilni tehniki injiciranja.
B. Take off the pen cap. C. Check the appearance of your insulin. 
C. Preverite videz insulina.
Apidra in cartridges is only suitable for injecting just under the skin using a reusable pen. 
Zdravilo Apidra v vložku je primerno samo za injiciranje tik pod kožo z injekcijskim peresnikom za večkratno uporabo.
When compared with soluble human insulin, if hypoglycaemia occurs after an injection with rapid acting analogues, it may occur earlier. 
Po injiciranju hitrodelujočih analogov se lahko hipoglikemija, če do nje pride, pojavi bolj zgodaj kot po topnem humanem insulinu.
2 vials of 10ml. 
2 viali z 10 ml.
Hypoglycaemia is a very commonly reported side effect (may affect more than 1 in 10 people). 
Hipoglikemija je zelo pogost neželeni učinek (pojavi se pri 1 od 10 bolnikov).
The average total GIR AUC between 0-1 hour was 102 ± 75 mg/kg and 158 ± 100 mg/kg with 0.2 and 0.4 Units/kg insulin glulisine, respectively, and was 83.1 ± 72.8 mg/kg and 112.3 ± 70.8 mg/kg with 0.2 and 0.4 Units/kg insulin lispro, respectively. 
Pri odmerku 0,2 enot/kg insulina lispro je bila 83,1 ± 72,8 mg/kg, pri odmerku 0,4 enot/kg insulina lispro pa 112,3 ± 70,8 mg/kg.
- The active substance is insulin glulisine. 
- Zdravilna učinkovina je insulin glulisin.
NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Apidra SoloStar 100 Units/ml solution for injection Insulin glulisine 
IME ZDRAVILA IN POT(I) UPORABE Apidra SoloStar 100 enot/ml raztopina za injiciranje insulin glulisin
Apidra 100 Units/ml solution for injection in a cartridge EU/1/04/285/005-012 
Apidra 100 enot/ml raztopina za injiciranje v vložku EU/1/04/285/005-012